No paralogue variants have been mapped to residue 610 for CACNA1C.
CACNA1C | LQAYFVSLFNRFDCFVVCGGILETILVETK>I<MSPLGISVLRCVRLLRIFKITRYWNSLSNL | 640 |
CACNA1A | TRPYFHSSFNCFDCGVIIGSIFEVIWAVIK>P<GTSFGISVLRALRLLRIFKVTKYWASLRNL | 603 |
CACNA1B | PRSYFRSSFNCFDFGVIVGSVFEVVWAAIK>P<GSSFGISVLRALRLLRIFKVTKYWSSLRNL | 599 |
CACNA1D | LQAYFVSLFNRFDCFVVCGGITETILVELE>I<MSPLGISVFRCVRLLRIFKVTRHWTSLSNL | 659 |
CACNA1E | PRLYFHSSFNCFDFGVTVGSIFEVVWAIFR>P<GTSFGISVLRALRLLRIFKITKYWASLRNL | 592 |
CACNA1F | PSAYVSSFFNRFDCFVVCGGILETTLVEVG>A<MQPLGISVLRCVRLLRIFKVTRHWASLSNL | 645 |
CACNA1G | PFGYIKNPYNIFDGVIVVISVWEIVGQQGG>-<----GLSVLRTFRLMRVLKLVRFLPALQRQ | 854 |
CACNA1H | PLGYIRNPYNIFDGIIVVISVWEIVGQADG>-<----GLSVLRTFRLLRVLKLVRFLPALRRQ | 904 |
CACNA1I | LFDYLRNPYNIFDSIIVIISIWEIVGQADG>-<----GLSVLRTFRLLRVLKLVRFMPALRRQ | 751 |
CACNA1S | LRQYFMSIFNRFDCFVVCSGILEILLVESG>A<MTPLGISVLRCIRLLRIFKITKYWTSLSNL | 548 |
SCN10A | PYYYFQKKWNIFDCIIVTVSLLELGVAKKG>-<----SLSVLRSFRLLRVFKLAKSWPTLNTL | 776 |
SCN11A | PYHYFRRGWNIFDSIVALLSFADVMNCVLQ>K<R---SWPFLRSFRVLRVFKLAKSWPTLNTL | 690 |
SCN1A | PYYYFQEGWNIFDGFIVTLSLVELGLANVE>-<----GLSVLRSFRLLRVFKLAKSWPTLNML | 879 |
SCN2A | PYYYFQEGWNIFDGFIVSLSLMELGLANVE>-<----GLSVLRSFRLLRVFKLAKSWPTLNML | 870 |
SCN3A | PYYYFQEGWNIFDGIIVSLSLMELGLSNVE>-<----GLSVLRSFRLLRVFKLAKSWPTLNML | 871 |
SCN4A | PYEYFQQGWNIFDSIIVTLSLVELGLANVQ>-<----GLSVLRSFRLLRVFKLAKSWPTLNML | 689 |
SCN5A | PYYYFQQGWNIFDSIIVILSLMELGLSRMS>-<----NLSVLRSFRLLRVFKLAKSWPTLNTL | 828 |
SCN7A | PYGYFQVGWNIFDSMIVFHGLIELCLANVA>-<----GMALLRLFRMLRIFKLGKYWPTFQIL | 616 |
SCN8A | PYYYFQEGWNIFDGFIVSLSLMELSLADVE>-<----GLSVLRSFRLLRVFKLAKSWPTLNML | 864 |
SCN9A | PYEYFQVGWNIFDSLIVTLSLVELFLADVE>-<----GLSVLRSFRLLRVFKLAKSWPTLNML | 844 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.I610V | c.1828A>G | Putative Benign | SIFT: Polyphen: |